FDA Proposes Plan for Spending $500 Million in Cures Act Funding

The FDA’s proposed plan for spending the $500 million allocated by the 21st Century Cures Act through fiscal 2025 prioritizes patient-focused drug development, qualification of biomarkers, and the use of real-world evidence.
Source: Drug Industry Daily